BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 22037474)

  • 1. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
    Giovino C; Ayensu I; Tetteh J; Boateng JS
    Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pH responsive polymethacrylic acid-chitosan-polyethylene glycol nanoparticles for oral peptide delivery.
    Sajeesh S; Sharma CP
    J Biomed Mater Res B Appl Biomater; 2006 Feb; 76(2):298-305. PubMed ID: 16130147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid.
    Angadi SC; Manjeshwar LS; Aminabhavi TM
    Int J Biol Macromol; 2010 Aug; 47(2):171-9. PubMed ID: 20471411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
    Fan W; Yan W; Xu Z; Ni H
    Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-g-PEG nanoparticles ionically crosslinked with poly(glutamic acid) and tripolyphosphate as protein delivery systems.
    Papadimitriou SA; Achilias DS; Bikiaris DN
    Int J Pharm; 2012 Jul; 430(1-2):318-27. PubMed ID: 22521711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel method for the synthesis of the PEG-crosslinked chitosan with a pH-independent swelling behavior.
    Kulkarni AR; Hukkeri VI; Sung HW; Liang HF
    Macromol Biosci; 2005 Oct; 5(10):925-8. PubMed ID: 16208628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication and caffeine release from Fe3O4/P(MAA-co-NVP) magnetic microspheres with controllable core-shell architecture.
    Di HW; Luo YL; Xu F; Chen YS; Nan YF
    J Biomater Sci Polym Ed; 2011; 22(4-6):557-76. PubMed ID: 21144259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
    Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
    J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
    Sawant KP; Fule R; Maniruzzaman M; Amin PD
    Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors.
    Chen S; Liu M; Jin S; Wang B
    Int J Pharm; 2008 Feb; 349(1-2):180-7. PubMed ID: 17900834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation on the properties of methoxy poly(ethylene glycol)/chitosan graft co-polymers.
    Deng L; Qi H; Yao C; Feng M; Dong A
    J Biomater Sci Polym Ed; 2007; 18(12):1575-89. PubMed ID: 17988521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.